Orbimed Advisors LLC Amarin Corp Plcuk Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $998,400 - $5.37 Million	-249,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $397,290 - $687,420	28,500 Added 12.89%	249,600 $5.35 Million
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $6.9 Million - $11.5 Million	-496,500 Reduced 69.19%	221,100 $3.35 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $4.07 Million - $5.13 Million	250,000 Added 53.46%	717,600 $13.9 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $4.88 Million - $8.63 Million	386,600 Added 477.28%	467,600 $9.71 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $1.01 Million - $1.86 Million	81,000 New	81,000 $1.1 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $190M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.